Horizon Pharma buying Hyperion for about $1.1 billion
Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders.
Mar 30, 2015
0
4
Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders.
Mar 30, 2015
0
4
On 28 April 2016 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a search for evidence-based guidelines on the treatment of people with rheumatoid arthritis. The aim of the ...
May 6, 2016
0
1
A clinical trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR) led by professors from the Universities of Liverpool and Bristol has discovered a drug combination that could help thousands ...
Apr 27, 2017
0
0
British supermarket chain Asda on Tuesday recalled all of its budget corned beef range after veterinary drug phenylbutazone was found in some samples.
Apr 9, 2013
0
0